These studies collectively highlight the potential role of CCX832 in reducing cancer cell invasion and progression by inhibiting the chemerin/ChemR23 signaling pathway, offering a promising therapeutic strategy for managing gastrointestinal cancers. This evidence concerns the gene CMKLR1 and cancer.